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Aquaglyceroporins (AQP3, AQP7, AQP9 and AQP10) encompass a 
subfamily of aquaporins that allow the 
movement of water and other small sol-
utes, especially glycerol, through cell 
membranes. Adipose tissue constitutes 
a major source of glycerol via AQP7. We 
have recently reported that, in addition 
to the well-known expression of AQP7 in 
adipose tissue, AQP3 and AQP9 are also 
expressed in omental and subcutaneous 
fat depots. Moreover, insulin and leptin 
act as regulators of aquaglyceroporins 
through the PI3K/Akt/mTOR pathway. 
AQP3 and AQP7 appear to facilitate 
glycerol efflux from adipose tissue while 
reducing the glycerol influx into hepato-
cytes via AQP9 to prevent the excessive 
lipid accumulation and the subsequent 
aggravation of hyperglycemia in human 
obesity. This Extra View focuses on the 
control of glycerol release by aquaglycer-
oporins in the adipose tissue and briefly 
discusses the importance of glycerol as 
a substrate for hepatic gluconeogenesis, 
pancreatic insulin secretion and cardiac 
ATP production.
Aquaglyceroporins and Glycerol 
as Metabolic Substrate
Over the past four decades, evidence for 
the existence of physiological systems 
aimed at body weight and energy homeo-
stasis has been provided.1 The adipose 
tissue has been extensively investigated 
and has been revealed to act as an endo-
crine organ that secretes a large number 
of hormones, growth factors, enzymes, 
cytokines, complement factors and 
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matrix proteins, collectively termed as 
adipokines.2 Upper body excess adipos-
ity is associated with increased incidence 
of metabolic disturbances, elevated risk 
of cardiovascular disease and premature 
death.3-5 Additionally, selective reduction 
of visceral adiposity with diet, exercise 
or bariatric surgery is accompanied by 
improvements in intermediary metabo-
lism.6,7 In spite of the growing under-
standing of the fundamental biology of 
energy homeostasis, it is evident that cru-
cial pathways have yet to be identified. 
Aquaglyceporins, integral plasma mem-
brane proteins with proven transport and 
signaling capabilities, have emerged as key 
players in shifting the focus of obesity and 
insulin resistance development.8,9
Aquaporins are channel-forming inte-
gral membrane proteins that allow the 
movement of water across the cell mem-
branes.10,11 These selective channels belong 
to the large superfamily of major intrinsic 
proteins (MIP) transmembrane channels 
and have been found in virtually every 
living organism, including eubacteria, 
archaea, fungi, protozoa, plants and ani-
mals. Both site-directed mutagenesis 
and high-resolution electron microscopy 
studies have revealed that the secondary 
structure of aquaporins contains six trans-
membrane α-helices with two highly con-
served non-bilayer-spanning loops with 
the motif asparagine-proline-alanine.12 
The three-dimensional structure of aqua-
porins resembles an hourglass;13,14 within 
the lipid bilayer, aquaporins form a tet-
rameric quaternary structure, with each 
monomer defining a single pore.14 To date, 
13 mammalian aquaporins (AQP0-12) 
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Lipogenesis and Lipolysis  
(AQP3 and AQP7)
Adipose tissue constitutes the most impor-
tant source of plasma glycerol.15 To date, 
AQP7 was considered the unique glycerol 
channel in the adipose tissue, but it has 
been recently shown that AQP3 and AQP9 
represent novel additional pathways for the 
transport of glycerol in human adipocytes 
(Fig. 1A).20,21 Furthermore, the existence 
of other yet-undiscovered glycerol facilita-
tors cannot be discarded.21,22 Teleological 
reasons for the presence of several glycerol 
channels in adipocytes include the com-
plex and redundant signaling network 
also serves as an energy substrate for 
pancreatic cells and cardiomyocytes via 
the glycerol-3-phosphate shuttle, a reac-
tion that allows the NADH synthesized 
in the cytosol by glycolysis to contribute 
to the oxidative pathway in the mito-
chondria to generate ATP.19 Thus, the 
regulation of glycerol transport by aqua-
glyceroporins contributes to the control 
of fat accumulation, glucose homeostasis, 
cardiac energy production and pancre-
atic insulin secretion, among other func-
tions. The present Extra View focuses on 
advances in the metabolic and cardiac 
effects of aquaglyceroporins in rodents 
and humans.
have been identified. Functional studies 
have defined a subgroup of aquaporins 
(AQP3, AQP7, AQP9 and AQP10) as 
aquaglyceroporins, given their permeabil-
ity, not only to water, but also to small sol-
utes, such as glycerol and urea.8,10
Circulating glycerol results from fat 
lipolysis, diet-derived glycerol or glycerol 
reabsorbed in the proximal tubules.15-17 
Glycerol represents an important metab-
olite for the control of fat accumulation, 
as the carbon backbone of triacylglycer-
ols (TAG) and for glucose homeostasis, 
given that glycerol constitutes the major 
substrate for hepatic gluconeogenesis 
during fasting.16,18 In addition, glycerol 
Figure 1. Proposed role of aquaglyceroporins in lipolysis and lipogenesis. (a) immunohistochemical detection of aQP3, aQP7 and aQP9 in omental 
adipose tissue obtained from obese patients (magnification x400). (B) in response to lipogenic conditions, adipocytes synthesize triacylglycerols from 
FFa and glycerol-3-phosphate. LPL and fatty acid transporters (FaBP, FatP and CD36) facilitate the FFa transport across the membrane. Glycerol-
3-phosphate proceeds from: (1) glucose, (2) glycerol from HSL-dependent lipolysis which is phosphorylated by GK or (3) aQP9-mediated-glycerol 
uptake. Lipolytic stimuli are characteristically embodied by stimulation of adrenergic receptors by catecholamines, leading to the translocation of 
HSL to the lipid droplets and its activation as well as to a parallel translocation of aQP3 and aQP7 to the plasma membrane to facilitate the glycerol 
release. interestingly, leptin and catecholamines downregulate aQP7 expression, suggesting a negative feedback regulation in lipolytic states to 
restrict glycerol release from adipocytes. CM, chylomicron; CD, fatty acid translocase; FFa, free fatty acids; FaBP, fatty acid binding protein; FatP, fatty 
acid transporter protein; GK, glycerol kinase; GLUt4, glucose transporter 4; HSL, hormone sensitive lipase; LPL, lipoprotein lipase; taG, triacylglycerols; 
vLDL, very low density lipoprotein.
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glycerol efflux from murine 3T3-L1 adi-
pocytes in response to the β-adrenergic 
agonist isoproterenol-induced lipolytic 
stimulus via its translocation from the 
cytosolic fraction (AQP3) or lipid droplets 
(AQP7) to the plasma membrane.21,33-35 
Short-term treatment with isoproter-
enol induces AQP3 and AQP7 transloca-
tion without changes in their expression, 
whereas long-term stimulation with iso-
proterenol reduces the expression of Aqp7 
in murine 3T3-L1 cells.21,36 Another lipo-
lytic factor, such as the adipocyte-derived 
hormone leptin, has been also shown to 
repress AQP7 protein expression via the 
PI3K/Akt/mTOR signaling cascade,21 
suggesting a negative feedback regulation 
in lipolytic states to restrict glycerol release 
from fat cells. Moreover, a recent study has 
shown that carboxymethyl chitin, a muco-
polysaccharide with proposed anti-obesity 
properties, stimulates lipolysis by increas-
ing HSL and AQP7 expression levels in 
3T3-L1 adipocytes.37 AQP7 appears to be 
one of the main channels for glycerol release 
from adipocytes. In this sense, it has been 
shown that adipocytes of Aqp7-deficient 
mice exhibit a higher intracellular glycerol 
content than those of wild-type mice.38,39 
In humans, the only subject homozygous 
for the AQP7 missense mutation (G264V) 
identified so far exhibited normal body 
weight and TAG concentrations, but he 
did not show an exercise-induced increase 
in glycerol release in spite of elevated 
plasma noradrenaline concentrations.29
Human obesity is associated with an 
altered expression profile of aquaporins in 
adipose tissue.20,40-43 Fat depot-specific dif-
ferences in the gene expression of AQP7 in 
human obesity have been reported. Thus, 
an overexpression of AQP7 in omental 
adipose tissue suggests an increase in the 
overall lipolytic capacity, while a repres-
sion of AQP7 in subcutaneous fat points to 
the promotion of an intracellular glycerol 
accumulation and a progressive adipocyte 
hypertrophy.20,21,40-42 Human obesity-
associated T2D is related to an additional 
alteration of the adipose expression profile 
of AQP3, AQP7 and AQP9 compared to 
obese normoglycemic subjects. These find-
ings suggest that the regulation of aqua-
glyceroporins in human adipose tissue is 
more related to insulin resistance than to 
obesity.21 Interestingly, it has been shown 
of LPL and, hence, through FFA uptake 
after binding to its receptor in adipocytes.8 
Under physiological conditions, insulin 
regulates the expression of aquaglyceropo-
rins to either increase or decrease glycerol 
uptake and/or release from adipocytes.17,18 
Insulin reportedly represses the expression 
of Aqp7 gene in murine adipocytes through 
negative insulin response elements (IRE) 
in its gene promoter.24,28 Interestingly, 
insulin increases the protein expression 
of AQP3, AQP7 and AQP9 in human 
adipocytes through the phosphatidyl-
inositol-3-kinase (PI3K)/Akt/mammalian 
target of rapamycin (mTOR) signaling 
pathway,21 suggesting divergent effects 
of insulin on the regulation of aquaglyc-
eroporins in humans compared to rodents. 
Plausible explanations for these diverse 
effects of insulin in humans compared to 
rodents might be related to species-specific 
differences in the physiological relevance 
of aquaglyceroporins (mouse vs. human) 
based on the following facts: (1) glycerol 
becomes the major substrate for hepatic 
gluconeogenesis in rodents during fasting 
and post-absorptive states, while pyru-
vate constitutes the main substrate of the 
gluconeogenic pathway in humans;15,18 
(2) the rare cases of human AQP3 and 
AQP7 deficiency identified so far do not 
resemble the same evident phenotypic 
characteristics observed in mice29,30 and 
(3) the expression of aquaglyceroporins 
is elevated in insulin-resistant states,28,31 
resulting in increased plasma glycerol and 
hepatic glucose production in obese, insu-
lin-resistant subjects.21,29
In circumstances of negative energy 
balance, such as fasting or exercise, TAG 
are hydrolyzed to glycerol and FFA by 
the adipose triglyceride lipase (ATGL) 
as well as the hormone-sensitive lipase 
(HSL) and released into the bloodstream. 
Catecholamines (noradrenaline and 
adrenaline) regulate lipolysis through 
lipolytic β-adrenoceptors (β
1
, β
2
 and β
3
) 
and anti-lipolytic α
2
-adrenoceptors.32 The 
β-adrenoceptors couple to G
s
 proteins that 
activate adenylate cyclase, leading to an 
increase in cAMP production, which is 
followed by activation of protein kinase A 
(PKA) that induces HSL phosphorylation 
and translocation from the cytosol to the 
lipid droplets, thereby increasing lipoly-
sis (Fig. 1B). AQP3 and AQP7 facilitate 
involved in the regulation of lipid and 
glucose metabolism. The redundancy of 
proteins exerting similar biological func-
tions is usual in physiology, in particular 
with biologically critical processes, e.g., 
the main glucose transporter in insulin-
sensitive tissues is GLUT4, but other 
glucose transporters GLUT1-12 are also 
expressed and active in liver, adipose tissue 
or skeletal muscle.23 Aquaglyceroporins 
display different subcellular localization in 
murine 3T3-L1 adipocytes; while AQP3 is 
present in the plasma membrane and cyto-
plasm, AQP7 resides predominantly in the 
cytoplasm upon the lipid droplets, whereas 
AQP9 is constitutively expressed in the 
plasma membranes.21 The main function 
of aquaglyceroporins in adipocytes is the 
control of glycerol uptake and release, two 
key steps for TAG synthesis (lipogenesis) 
and hydrolysis (lipolysis), respectively.8 In 
this regard, aquaglyceroporins are regu-
lated by lipogenic (mainly insulin) and 
lipolytic (exemplified by leptin and cat-
echolamines) hormones (Fig. 1B).21
Under lipogenic conditions, such as 
overnutrition or lack of exercise, adipo-
cytes synthesize TAG from the esteri-
fication of free fatty acids (FFA) with 
glycerol-3-phosphate. Several membrane 
proteins, including fatty acid-binding pro-
tein (FABP), fatty acid translocase (FAT, 
CD36) or fatty acid transporter protein 
(FATP), facilitate the FFA transport across 
the membrane.24 In addition, lipoprotein 
lipase (LPL) (located on the surface of adi-
pocytes) removes FFA from chylomicrons 
and very low-density lipoproteins.25 The 
other metabolite required for TAG bio-
synthesis, glycerol-3-phosphate, derives 
from three metabolic sources: (1) glucose, 
since glycerol-3-phosphate constitutes 
a secondary metabolite of glycolysis;8,18 
(2) lipolysis-derived glycerol, which is 
phosphorylated by glycerol kinase (GK)26 
and (3) aquaglyceroporin-mediated glyc-
erol uptake (Fig. 1B).21 AQP9 appears 
to be the channel responsible for glycerol 
influx into adipocytes, since it is a con-
stitutively expressed integral membrane 
protein not acutely regulated by vesicular 
trafficking.21,27 Insulin stimulates lipogen-
esis through the stimulation of glucose 
uptake after the translocation of glucose 
transporter 4 (GLUT4) to the plasma 
membrane as well as through the activation 
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The coordinated regulation of adi-
pose and hepatic aquaglyceroporins is 
required for the control of whole-body 
glucose homeostasis and lipid accumu-
lation in rodents and humans.21,28,42 In 
this sense, Aqp3-deficient mice develop 
nephrogenic diabetes insipidus,50 Aqp7 
deletion leads to obesity22,38,39 and Aqp9 
deficiency favors the onset of diabe-
tes.51 Insulin represses adipose Aqp7 and 
hepatic Aqp9 gene expression through the 
negative IRE in their gene promoters in 
rodents.24,28,52 Murine Aqp7 deficiency is 
associated with a failure of the antilipo-
lytic action of insulin, due to impaired 
IRS-1-associated PI3K activity in adipo-
cytes as well as a defective insulin-induced 
inhibition of hepatic gluconeogenesis, a 
result of low IRS-2-associated PI3K activ-
ity in hepatocytes.38 Contrary to what 
is observed in rodents, the rare cases of 
human AQP3 and AQP7 deficiency do not 
resemble the phenotypic characteristics 
observed in transgenic knockout mice. 
70–90% of the whole-body glycerol metab-
olism.15 AQP7 represents the main gateway 
for the delivery of fat-derived glycerol, 
while glycerol enters hepatocytes via AQP9, 
where it is converted into glycerol-3-phos-
phate, a precursor of gluconeogenesis and 
a direct source for TAG synthesis (Fig. 
2).8,18 Pyruvate also constitutes a source 
for glycerol-3-phosphate by the enzymatic 
activity of pyruvate carboxylase (PC) 
and phosphoenolpyruvate carboxykinase 
(PEPCK).15 Insulin inhibits gluconeogen-
esis by reducing the activity of PEPCK as 
well as by blocking glucogenolysis (i.e., the 
conversion of glycogen polymers to glucose 
monomers).18 AQP9 constitutes the most 
important glycerol channel in hepatocytes 
and is localized at the sinusoidal plasma 
membrane that faces the portal vein.46-48 
However, AQP3 and AQP7 are also 
expressed in human hepatic cells, thereby 
demanding the need for a functional expla-
nation for the redundancy of diverse glyc-
erol channel in the same tissue.21,49
that the administration of the insulin-sen-
sitizing agents thiazolidinediones (TZD), 
e.g., pioglitazone and rosiglitazone, aug-
ments the expression of adipose AQP7 in 
rodents without increasing glycerol release 
from adipocytes.44,45 This apparent para-
dox results from the parallel increase of 
GK expression and activity induced by 
TZD in adipocytes, favoring the recycling 
of glycerol for TAG synthesis instead of 
stimulating the release of glycerol to the 
bloodstream.26,45 Therefore, the undesir-
able increase of adipose AQP7 expression 
in insulin-resistant states, plausibly lead-
ing to elevated plasma glycerol levels and, 
consequently, to hepatic gluconeogenesis, 
can be overcome by an increased glycerol 
recycling in adipocytes using TZD.
Hepatic Gluconeogenesis  
and TAG Synthesis (AQP9)
The liver plays a central role in glycerol 
metabolism, since it is responsible for 
Figure 2. Participation of aQP9 in hepatic gluconeogenesis and steatosis. During fasting, adipocytes induce glycerol release through aQP3 and 
aQP7 while hepatocytes favor glycerol uptake through aQP9. Glycerol is phosphorylated by GK to produce glycerol-3-phosphate, a precursor of 
gluconeogenesis and a direct source of glycerol-3-phosphate for de novo synthesis of triacylglycerols. Coordinated regulation of adipose and hepatic 
aquaglyceroporins is necessary to maintain a correct balance between fat accumulation, hepatic gluconeogenesis and steatosis. FFa, free fatty acids; 
GK, glycerol kinase; GLUt, glucose transporter; PC, pyruvate carboxylase; PeP, phosphoenolpyruvate; PePCK, phosphoenolpyruvate carboxykinase; 
taG, triacylglycerols.
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rapid influx of Ca2+.56,60,62 The consequent 
increase in cytosolic Ca2+ triggers the exo-
cytosis of insulin-containing secretory 
granules.60 In this sense, Aqp7-deficient 
mice show elevated glycerol content and 
increased GK activity in β cells, thereby 
promoting an increase in islet TAG lev-
els.58 Moreover, Aqp7-knockout mice show 
hyperinsulinemia and increased pancre-
atic insulin-1 and insulin-2 transcript 
levels.38,58 In addition, Aqp7 deficiency is 
associated with higher basal and high glu-
cose-induced insulin secretion, probably 
as a consequence of the increased pan-
creatic intracellular glycerol content.38,58 
Interestingly, the increased insulin secre-
tion of Aqp7-deficient mice is accompa-
nied by a reduction in the islet cell number 
and total β cell mass, indicating a more 
efficient insulin biosynthesis and secretion 
in these cells.
Diabetes occurs when there is inad-
equate insulin production in response to 
the body’s demand for the hormone.56 
Type 1 diabetes is associated with abso-
lute insulin deficiency, which occurs when 
β cells are destroyed by autoimmunity. 
In insulin-resistant states, such as obe-
sity and type 2 diabetes, expansion of 
the β-cell mass occurs in response to the 
increased demand, but diabetes does not 
occur unless there is concomitant β-cell 
dysfunction.56 AQP7, which controls the 
pancreatic intracellular glycerol content, 
appears to play a key role in regulating 
pro-insulin biosynthesis and insulin secre-
tion.58-60 Human obesity and obesity-asso-
ciated T2D have been associated with an 
altered gene expression profile of AQP7 in 
insulin-sensitive tissues, such as adipose 
tissue and liver.21,40-43 Therefore, further 
studies analyzing the expression or regu-
lation of AQP7 in pancreatic β cells are 
needed to shed light on its contribution to 
the development of T2D.
Energy Production in Skeletal 
Muscle and Heart (AQP7)
Glycerol levels in the interstitial fluid of 
human skeletal muscle are much higher 
than plasma levels and approach the 
concentrations found in adipose tissue.63 
AQP7 is the aquaglyceroporin respon-
sible for glycerol uptake in murine type 2 
myofibers,33 while both AQP3 and AQP7 
AQP9, but prolonged exposure to acetalde-
hyde reduces AQP9 expression, suggesting 
a negative feedback regulation.55 Exposure 
to ethanol, in spite of not modifying 
AQP9 expression, enhances the activity of 
GK and PEPCK, leading to increased for-
mation of glycerol-3-phosphate, thereby 
contributing to alcoholic fatty liver.55
Pancreatic Insulin Secretion 
(AQP7)
Circulating glucose concentrations con-
stitute the most physiologically relevant 
influence on the regulation of pro-insulin 
biosynthesis and insulin secretion in pan-
creatic β-cells.56 Nonetheless, glycerol 
is also metabolized in the pancreas and 
shows the potential to stimulate insulin 
production and secretion.57 AQP7 seems to 
embody the unique aquaglyceroporin that 
mediates the rapid entry of glycerol into 
β pancreatic cells of mice and rats, being 
localized in pancreatic islets but not in the 
pancreatic ducts or the acinar pancreas.58-60 
The increase in intracellular glycerol and 
the consequent activation of GK activity, 
in turn, stimulate the pro-insulin mRNA 
and insulin secretion, probably through 
their participation in the glycolysis and 
glycerol-phosphate shuttle activities in β 
cells (Fig. 3).57,58 The glycerol-3-phosphate 
shuttle pathway constitutes a mechanism 
that allows the NADH synthesized in 
the cytosol by glycolysis to contribute to 
the oxidative phosphorylation pathway in 
the mitochondria to generate ATP.19 Two 
enzymes are mainly involved in this shut-
tle, the cytosolic and the mitochondrial 
glycerol-3-phosphate dehydrogenases 
(GPD).61 The cytosolic GPD converts 
dihydroxyacetone phosphate (DHAP) 
to glycerol-3-phosphate by oxidizing one 
molecule of NADH to NAD+. In turn, 
glycerol-3-phosphate can be reconverted 
to DHAP by the mitochondrial GPD 
by reducing one molecule of FAD+ to 
FADH
2
. The electrons from FADH
2
 feed 
into the oxidative phosphorylation path-
way at coenzyme Q, thereby producing 
ATP. The raise in the cytoplasmic ATP/
ADP ratio produced during glycolysis and 
the glycerol-phosphate shuttle closes the 
K
ATP
 channels and depolarizes the plasma 
membrane, allowing the opening of volt-
age-dependent calcium channels and a 
The individuals carrying a homozygous 
mutation in AQP3 and AQP7 are neither 
obese nor diabetic.29,30 The regulation of 
aquaglyceroporins induced by insulin in 
human hepatocytes also appears to be dif-
ferent from the control that takes place 
in mice, since insulin upregulates the 
expression of aquaglyceroporins in human 
hepatic cells.21 Insulin-mediated elevation 
of AQP3 and AQP7, two glycerol chan-
nels surrounding the lipid droplets, may 
reflect an increased intrahepatocellular 
TAG content, given that insulin induces 
hepatic steatosis through the activation 
of the expression of lipogenic genes.53 On 
the other hand, insulin-induced AQP9 
upregulation might favor glycerol influx 
into hepatocytes.21 Obese patients with 
T2D exhibit a decreased hepatic AQP9, 
compatible with a compensatory mecha-
nism aimed at reducing the glycerol entry 
into hepatocytes and further enhancing 
the development of hyperglycemia.21,42,43
Non-alcoholic fatty liver disease 
(NAFLD) is characterized by TAG 
accumulation in hepatocytes and ranges 
from simple fatty liver (steatosis) to non-
alcoholic steatohepatitis (NASH) and 
to cirrhosis (irreversible, advanced scar-
ring of the liver).54 AQP9 has been pro-
posed as a pharmacological therapy for 
NAFLD-NASH.54 In this sense, our 
group provided evidence that hepatic 
AQP9 mRNA was negatively correlated 
with intrahepatic lipid content in obese 
patients.21 Nevertheless, Miranda and 
colleagues did not find any relationship 
between AQP9 expression and the degree 
of hepatic steatosis or fibrosis in patients 
with morbid obesity.43 In line with this 
observation, no apparent histological 
abnormalities were shown in hepatic sec-
tions of transgenic Aqp9 knockout mice.51 
These contradictory observations raise 
some questions as regards the involve-
ment of AQP9 in the etiopathology of 
NAFLD-NASH and deserve future stud-
ies to outline its potential contribution. 
Hepatocellular ballooning is one of the 
histological hallmarks of alcoholic steato-
hepatitis, while it is much less common in 
NASH. Acetaldehyde, an oxidation prod-
uct derived from ethanol by the action of 
the hepatic enzyme alcohol dehydroge-
nase, induces a rapid increase in glycerol 
uptake and cell size in rat hepatocytes via 
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show reduced cardiac glycerol content, 
lower expression of enzymes related to 
the glycerol-3-phosphate shuttle, such as 
GK and GPD2, as well as lower intracel-
lular ATP levels, suggesting a possible dis-
turbance of cardiac glycerol metabolism 
and energy production.19 Surprisingly, 
under basal conditions, Aqp7-knockout 
mice develop normal cardiac phenotypes. 
However, Aqp7-deficient mice develop 
cardiac hypertrophy and defective left ven-
tricular contraction following an isoproter-
enol challenge and subsequently, exhibit a 
higher mortality than wild-type counter-
parts, which suggests an impaired myo-
cardial adaptation to pressure overload.19,68 
In humans, the adipose tissue constitutes 
the major expression site of AQP7,69 but 
Sjöholm and colleagues showed that the 
heart displays the second tissue with high-
est expression of AQP7, both by microarray 
and real-time PCR analyses.70 Therefore, 
further studies are needed to better assess 
the pathophysiological relevance of car-
diac AQP7 in humans.
mitochondria to generate ATP for the 
contraction of myofilaments (Fig. 4).19 
The mitochondrial creatine kinase cata-
lyzes the reaction transforming ATP and 
creatine into phosphocreatine and ADP.66 
Phosphocreatine rapidly diffuses from 
the mitochondria to the myofibrils, where 
myofibrillar creatine kinase catalyzes the 
restauration of ATP from phosphocreatine. 
ATP is used by myofibrillar ATPase and 
other ATP-consuming reactions, such as 
sarcolemmal and sarcoplasmic reticulum 
pumps to carry out the contractile work.
AQP7 is apparently the sole glycerol 
facilitator in the murine heart, and it is 
localized in cardiac capillaries, fibroblasts 
and cardiomyocytes.19,67 Plasma glycerol is 
introduced into cardiomyocytes by AQP7 
and converted to glycerol-3-phosphate 
by the enzymatic activity of GK (Fig. 4). 
The subsequent entrance into the glycerol-
3-phosphate shuttle will lead to increased 
ATP production and the contraction of 
myofibrils. In this sense, it has been shown 
that transgenic mice lacking Aqp7 gene 
constitute the glycerol gateways in human 
type I and type II myofibers.64,65 Glycerol 
is converted to glycerol-3-phosphate by 
GK and it is readily used for TAG syn-
thesis, but it can also be diverted to form 
glycolytic intermediates that are, in turn, 
converted to glycogen or lactate.63 Given 
the elevated glycerol levels in the intersti-
tial fluid, it seems plausible that changes 
in aquaglyceroporins and/or GK activity 
in skeletal muscle may exert important 
influences on fuel deposition in this tissue.
The heart requires FFA and glucose 
for energy production in order to main-
tain its contractility.66 The oxidation of 
FFA supplies 60–90% of myocardial ATP, 
while glucose and lactate provide 10–40% 
of the cardiac energy production.19,66 
Interestingly, it has been recently described 
that the murine heart also utilizes glyc-
erol as energy substrate via the glycerol-
3-phosphate shuttle pathway, a mechanism 
that allows the NADH synthesized in the 
cytosol by glycolysis to contribute to the 
oxidative phosphorylation pathway in the 
Figure 3. Pancreatic aQP7, glycerol phosphate shuttle and insulin secretion. aQP7 mediates glycerol uptake in pancreatic β cells. Glycerol is phos-
phorylated to glycerol-3-phosphate by GK and, subsequently, glycerol-3-phosphate is converted to DHaP by the mitochondrial GPD. this reaction 
reduces equivalents into the mitochondrion for use in oxidative phosphorylation and is called the glycerol-3-phosphate shuttle. the increase in 
intracellular atP:aDP ratio induces the closure of atP-sensitive K+ channels, the cell membrane depolarization and the opening of voltage-sensitive 
Ca2+ channels. the raise in intracellular Ca2+ enhances the exocytosis of insulin-containing granules. GK, glycerol kinase; GLUt, glucose transporter; 
GPD, glycerol-3-phosphate dehydrogenase.
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extensively studied in human obesity and 
obesity-associated T2D.20,21,40-43 A strong 
increase in AQP9 transcripts was observed 
in synovial tissues from patients with 
osteoarthritis and rheumatoid arthritis, 
suggesting its relation to the pathogenesis 
of hydrarthrosis and inflammatory synovi-
tis.74 Interestingly, AQP3 mRNA levels are 
highly expressed in several human cancer 
cell types, including skin, esophageal, lin-
gual, lung, colorectal and gastric carcino-
mas.75-79 In this regard, AQP3 appears to 
play a critical role in basal and epidermal 
growth factor (EGF)-induced cancer cell 
migration and proliferation.77,80
Conclusion
In summary, given the versatile func-
tions of aquaglyceroporins, additional 
and unexpected roles of these glycerol 
channels are sure to emerge in the com-
ing years. Likewise, further investigations 
in novel mutations, SNPs or differential 
expression levels of aquaglyceroporins are 
needed to broaden our understanding of 
the implications of these glycerol pores in 
the onset of human diseases.
genes encoding aquaglyceroporins also 
represents an important approach to inves-
tigate their cardiometabolic effects. One 
single variation (G105C) in the AQP3 
gene was found in 11 patients (32%) with 
Menière’s disease, an episodic cochleoves-
tibular dysfunction of unknown etiology.72 
Prudente and colleagues identified one 
SNP (A953G) in the promoter region of 
the AQP7 gene, resulting in an impaired 
ability to bind the CCAAT/enhancer bind-
ing protein β (C/EBPβ) transcription fac-
tor.41 Furthermore, it was shown that the 
AQP7 gene expression was lower in adipose 
tissue of obese subjects. In addition, the 
A953G variant in the AQP7 promoter was 
associated with T2D in 977 Caucasians.41 
Recently, an intronic A/T (rs2414539) 
SNP in the AQP9 gene has been associated 
with femoral neck bone mineral density 
in postmenopausal women and may rep-
resent one of the susceptibility genes for 
phenotypes related to bone mass.73
Finally, altered gene and protein expres-
sion levels of aquaglyceroporins have been 
reported in several human diseases. To 
date, the impaired coordination of adipose 
and hepatic aquaglyceroporins have been 
Human Genetic Studies
The functional importance of glycerol 
channels in mammalian physiology and 
pathophysiology has been extensively 
studied by analyzing the phenotype of 
transgenic knockout mice lacking dif-
ferent aquaglyceroporins.10,11 Until now, 
information regarding the role of aqua-
glyceroporins in humans has been scarce. 
The rare cases of homozygous mutations 
in the coding region of the AQP3 and 
AQP7 genes identified so far do not resem-
ble the same evident phenotypic char-
acteristics observed in mice, since they 
were neither diabetic nor obese.29,30 In the 
Japanese population, the frequency of mis-
sense mutations (R12C, V59L, G264V) 
and silence mutations (A103A, G250G) 
of AQP7 was not associated with obesity 
or T2D, despite the absence of glycerol 
transport in a subject carrying the G264V 
mutation.29 Nevertheless, Ceperuelo-
Mallafré and colleagues reported one case 
homozygous for the G264V mutation 
with overweight and T2D.71
The detection of several single nucleo-
tide polymorphisms (SNPs) within the 
Figure 4. Cardiac aQP7, the glycerol phosphate shuttle and atP production. aQP7 facilitates glycerol uptake by cardiomyocytes. Glycerol is phos-
phorylated to glycerol-3-phosphate by GK that enters in the glycerol-3-phosphate shuttle to trigger atP production in the mitochondrial oxidative 
phosphorylation. the transfer of atP to the cytosol is achieved by the creatine kinase energy shuttle and is used for the contraction of myofilaments. 
DHaP, dihydroxyacetone phosphate; GK, glycerol kinase; GPD, glycerol-3-phosphate dehydrogenase.
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